Senores Pharmaceuticals Limited

IncreasedQuarterly

SENORESPharmaceuticalsMarket Cap₹6K Cr

Stake

2.29% → 3.44%

HSBC Mutual Fund

Mutual Fund

The move

HSBC Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 2.29% to 3.44% by acquiring 527,314 additional shares. This change in holding is worth ₹74.1 Cr at the current share price of ₹1405.10.

About Senores Pharmaceuticals Limited

Visit stock

A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.

About HSBC Mutual Fund

Visit investor

Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.

Get the next move the moment it happens.

Follow HSBC Mutual Fund and Senores Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Senores Pharmaceuticals Limited shareholders HSBC Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Senores Pharmaceuticals Limited

ICICI Prudential Mutual FundExited

ICICI Prudential Mutual Fund, which previously held 1.37 percent of Senores Pharmaceuticals Limited, has dropped off the company's disclosed shareholder list, indicating either a complete exit or a reduction below the 1 percent reporting threshold.

20 Jul 2026

Aditya Birla Sun Life InsuranceDecreased

Aditya Birla Sun Life Insurance reduced its stake in Senores Pharmaceuticals from 2.96% to 1.62% by selling 617,002 shares. The value of shares sold is ₹86.68 Cr at ₹1405.10 apiece.